Drug Target Review2024-10-22T12:00:08
The study identified which specific HERVs are important in increasing susceptibility for neurodegenerative diseases.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-09-22T07:00:00Z
Contributor Luca Lotta, Drug Target Review
2026-09-17T07:00:00Z
Contributor Dr Roland Bürli, Dr Francesca Capotosti and Dr Antonella Pirone, Drug Target Review
2026-09-10T08:41:00
Sponsored by DNA Genotek Inc.
2026-09-22T07:00:00
Contributor Luca Lotta, Drug Target Review
2023-11-24T12:06:45
Sponsored by Quantum-Si
2024-02-06T08:57:06
Sponsored by bit.bio
2026-08-06T06:08:00
Author Dr Jonathan Cohen-Gold
2026-06-15T11:00:00
Sponsored by Miltenyi Biotec
Site powered by Webvision Cloud